The latest US sector momentum visualization for 26 August 2026 shows three sectors in Leading, five in Improving, two in Weakening and one in Lagging. The chart indicates an active rotation environment, with Communication Services strengthening into Leading while Materials has reversed back into …
A Statement of Changes in Beneficial Ownership was filed on August 26, 2026, disclosing that GeoPark Ltd director Brian F. Maxted acquired 2,567 common shares on August 24, 2026, as part of a quarterly director grant.
Director Carlos Enrique Macellari filed a Form 4 with the SEC on August 26, 2026, disclosing the acquisition of common shares in GeoPark Ltd as part of a quarterly director compensation grant.
Director Constantin Papadimitriou filed a Form 4 with the SEC on August 26, 2026, reporting the acquisition of fully vested common shares of GeoPark Ltd as a quarterly director grant.
Ann Varanakis, Chief People Officer of LifeStance Health Group, Inc., filed a statement of changes in beneficial ownership on August 26, 2026, reporting a share disposition on August 24, 2026, in connection with the vesting of restricted stock units.
John F. Wilson, Executive Chairman and Director of Rollins Inc, filed a Form 4 on August 26, 2026, disclosing two gifts of common stock totaling 87,000 shares transacted on August 25, 2026.
A Form 4 filed on August 26, 2026 reports that Adam Taich, Chief Financial Officer of 10x Genomics, Inc. (NASDAQ:TXG), disposed of 17,166 shares of Class A Common Stock on August 24, 2026 to cover tax withholding obligations tied to the vesting of restricted …
Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, Inc. (NASDAQ:TXG), filed a Form 4 on August 26, 2026, reporting the sale of Class A Common Stock on August 24, 2026, to cover tax withholding obligations connected to the vesting of restricted …
A Form 4 filed on August 26, 2026 with the U.S. Securities and Exchange Commission shows Steven D. Gray, a director of Permian Resources Corp (NYSE:PR), disposed of 24,000 shares of Class A Common Stock through a gift transaction on August 26, 2026.
Serge Saxonov, Chief Executive Officer and Director of 10x Genomics, Inc., filed a Form 4 on August 26, 2026, reporting the sale of 18,545 shares of Class A Common Stock on August 24, 2026, to cover tax withholding obligations connected to the vesting of …